XOMA (XOMA) Revenue & Revenue Breakdown
XOMA Revenue Highlights
Latest Revenue (Y)
$4.76M
Latest Revenue (Q)
$11.09M
Main Geography (Y)
UNITED STATES
XOMA Revenue by Period
XOMA Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $4.76M | -21.06% |
2022-12-31 | $6.03M | -84.21% |
2021-12-31 | $38.16M | 29.86% |
2020-12-31 | $29.39M | 59.96% |
2019-12-31 | $18.37M | 246.67% |
2018-12-31 | $5.30M | -89.94% |
2017-12-31 | $52.69M | 846.98% |
2016-12-31 | $5.56M | -89.97% |
2015-12-31 | $55.45M | 193.90% |
2014-12-31 | $18.87M | -46.78% |
2013-12-31 | $35.45M | 4.94% |
2012-12-31 | $33.78M | -41.95% |
2011-12-31 | $58.20M | 72.99% |
2010-12-31 | $33.64M | -65.82% |
2009-12-31 | $98.43M | 44.78% |
2008-12-31 | $67.99M | -19.31% |
2007-12-31 | $84.25M | 185.62% |
2006-12-31 | $29.50M | 58.01% |
2005-12-31 | $18.67M | 409.39% |
2004-12-31 | $3.67M | -84.99% |
2003-12-31 | $24.41M | -18.49% |
2002-12-31 | $29.95M | 73.33% |
2001-12-31 | $17.28M | 159.48% |
2000-12-31 | $6.66M | 177.46% |
1999-12-31 | $2.40M | -61.90% |
1998-12-31 | $6.30M | -65.76% |
1997-12-31 | $18.40M | 411.11% |
1996-12-31 | $3.60M | 200.00% |
1995-12-31 | $1.20M | -29.41% |
1994-12-31 | $1.70M | 183.33% |
1993-12-31 | $600.00K | - |
XOMA Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | $11.09M | 644.03% |
2024-03-31 | $1.49M | -18.71% |
2023-12-31 | $1.83M | 120.84% |
2023-09-30 | $830.00K | -49.94% |
2023-06-30 | $1.66M | 279.41% |
2023-03-31 | $437.00K | -70.59% |
2022-12-31 | $1.49M | 229.49% |
2022-09-30 | $451.00K | -54.12% |
2022-06-30 | $983.00K | -68.36% |
2022-03-31 | $3.11M | -91.36% |
2021-12-31 | $35.94M | 3723.83% |
2021-09-30 | $940.00K | 4.33% |
2021-06-30 | $901.00K | 140.27% |
2021-03-31 | $375.00K | -98.64% |
2020-12-31 | $27.58M | 4851.53% |
2020-09-30 | $557.00K | 25.45% |
2020-06-30 | $444.00K | -44.78% |
2020-03-31 | $804.00K | 90.07% |
2019-12-31 | $423.00K | -95.22% |
2019-09-30 | $8.86M | 820.48% |
2019-06-30 | $962.00K | -88.17% |
2019-03-31 | $8.13M | 382.55% |
2018-12-31 | $1.69M | 88.06% |
2018-09-30 | $896.00K | -60.27% |
2018-06-30 | $2.25M | 387.04% |
2018-03-31 | $463.00K | -91.36% |
2017-12-31 | $5.36M | -85.19% |
2017-09-30 | $36.18M | 232.26% |
2017-06-30 | $10.89M | 4088.46% |
2017-03-31 | $260.00K | -50.38% |
2016-12-31 | $524.00K | -17.48% |
2016-09-30 | $635.00K | 43.34% |
2016-06-30 | $443.00K | -88.82% |
2016-03-31 | $3.96M | -91.78% |
2015-12-31 | $48.18M | 2223.19% |
2015-09-30 | $2.07M | -18.31% |
2015-06-30 | $2.54M | -4.22% |
2015-03-31 | $2.65M | -39.03% |
2014-12-31 | $4.35M | -15.34% |
2014-09-30 | $5.14M | -14.01% |
2014-06-30 | $5.97M | 75.16% |
2014-03-31 | $3.41M | -72.79% |
2013-12-31 | $12.53M | 98.57% |
2013-09-30 | $6.31M | -11.73% |
2013-06-30 | $7.15M | -24.35% |
2013-03-31 | $9.45M | 27.88% |
2012-12-31 | $7.39M | 1.94% |
2012-09-30 | $7.25M | -21.82% |
2012-06-30 | $9.28M | -5.98% |
2012-03-31 | $9.87M | 0.18% |
2011-12-31 | $9.85M | -39.32% |
2011-09-30 | $16.23M | -1.79% |
2011-06-30 | $16.52M | 5.96% |
2011-03-31 | $15.60M | 62.45% |
2010-12-31 | $9.60M | -11.90% |
2010-09-30 | $10.90M | 83.39% |
2010-06-30 | $5.94M | -17.50% |
2010-03-31 | $7.20M | -66.65% |
2009-12-31 | $21.60M | -21.24% |
2009-09-30 | $27.42M | 182.54% |
2009-06-30 | $9.71M | -75.55% |
2009-03-31 | $39.70M | 7.54% |
2008-12-31 | $36.92M | 367.70% |
2008-09-30 | $7.89M | -28.99% |
2008-06-30 | $11.12M | -7.80% |
2008-03-31 | $12.06M | -18.11% |
2007-12-31 | $14.72M | - |
XOMA Revenue Breakdown
XOMA Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
---|---|---|---|---|---|
Asia Pacific | $1.10M | $1.55M | $550.00K | $3.10M | $600.00K |
UNITED STATES | $3.66M | - | - | - | - |
United States | - | $4.48M | $2.61M | - | - |
Europe | - | - | $35.00M | $25.01M | $100.00K |
U | - | - | - | $1.27M | $17.67M |
XOMA Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
TNGX | Tango Therapeutics | $36.53M | $6.47M |
HOWL | Werewolf Therapeutics | $19.94M | $742.00K |
RVMD | Revolution Medicines, Inc. Warrant | $11.58M | - |
STOK | Stoke Therapeutics | $8.78M | $4.22M |
XOMA | XOMA | $4.76M | $11.09M |
CRNX | Crinetics Pharmaceuticals | $4.01M | $640.00K |
DSGN | Design Therapeutics | - | - |
RZLT | Rezolute | - | - |
CCCC | C4 Therapeutics | - | - |
DBTX | Decibel Therapeutics | - | - |
TALS | Tourmaline Bio | - | - |
DYN | Dyne Therapeutics | - | - |
PASG | Passage Bio | - | - |
ELYM | Eliem Therapeutics | - | - |
ACRV | Acrivon Therapeutics | - | - |
ACHL | Achilles Therapeutics | - | - |
CELC | Celcuity | - | - |
VINC | Vincerx Pharma | - | - |
THRD | Third Harmonic Bio | - | - |
EWTX | Edgewise Therapeutics | - | - |
SIOX | Sio Gene Therapies | - | - |
XOMA Revenue FAQ
What is XOMA’s yearly revenue?
XOMA's yearly revenue for 2023 was $4.76M, representing a decrease of -21.06% compared to 2022. The company's yearly revenue for 2022 was $6.03M, representing a decrease of -84.21% compared to 2021. XOMA's yearly revenue for 2021 was $38.16M, representing an increase of 29.86% compared to 2020.
What is XOMA’s quarterly revenue?
XOMA's quarterly revenue for Q2 2024 was $11.09M, a 644.03% increase from the previous quarter (Q1 2024), and a 568.64% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $1.49M, a -18.71% decrease from the previous quarter (Q4 2023), and a 240.96% increase year-over-year (Q1 2023). XOMA's quarterly revenue for Q4 2023 was $1.83M, a 120.84% increase from the previous quarter (Q3 2023), and a 23.35% increase year-over-year (Q4 2022).
What is XOMA’s revenue growth rate?
XOMA's revenue growth rate for the last 3 years (2021-2023) was -87.53%, and for the last 5 years (2019-2023) was -74.10%.